20260930_BRIS_Keterbukaan Informasi terkait Aksi Korporasi_32162265_lamp2.pdf

              INFORMATION IN CONNECTION WITH THE PROPOSED PMHMETD II

In connection with the proposed PMHMETD II, under this Inf ormation Disclosure, the Company intends
to issue a maximum of 6,800,000,000 (six billion eight hundred million) Series B shares of the
Company with a nominal value of Rp500,- per share (the “New Shares”).

The New Shares will be issued f rom the Company’s portf olio and listed on PT Bursa Ef ek Indonesia
(“IDX”) in accordance with the prevailing laws and regulations, including IDX Regulation No. I-A
concerning the Listing of Shares and Equity-Type Securities Other Than Shares Issued by Listed
Companies, as set out in the Appendix to the Decision of the Board of Directors of PT Bursa Efek
Indonesia No. Kep-00045/BEI/03-2026 dated 31 March 2026. The New Shares will rank pari passu in
all respects, including dividend rights, with the Company’s other issued and paid -up Series B shares.

The issuance of the New Shares will be carried out by granting pre-emptive rights in accordance with
the Capital Increase Regulation, and accordingly, PMHMETD II will be implemented subject to:

1.      Approval of the Company’s shareholders at the EGMS in relation to the proposed PMHMETD
        II, in accordance with the Company’s articles of association and the prevailing laws and
        regulations; and

2.      The Company’s Registration Statement to be submitted to OJK in connection with the proposed
        PMHMETD II, being declared ef f ective by OJK, in accordance with the prevailing laws and
        regulations.

For the avoidance of doubt, the Company reserves the right to issue part or all of the maximum number
of shares approved f or issuance pursuant to the EGMS resolution. The terms of PMHMETD II, including
the exercise price and the f inal number of New Shares to be issued, will be disclosed in the prospectus
to be issued in connection with PMHMETD II and made available in due course to eligible shareholders
in accordance with the prevailing laws and regulations. Subscription f or the Company’s shares will be
paid in cash.

              ESTIMATED TIMELINE FOR THE IMPLEMENTATION OF PMHMETD II

As required under the Capital Increase Regulation, the Company intends to submit the Registration
Statement f or PMHMETD II to the OJK af ter the requirements under the prevailing laws and regulations
have been f ulf illed, including approval at the Company’s EGMS, which is scheduled to be held on 6
November 2026. PMHMETD II will be implemented af ter the Registration Statement has been decl ared
ef f ective by the OJK.

Pursuant to Article 8 paragraph (3) of the Capital Increase Regulation, the period f rom the date of the
EGMS approval until the Registration Statement becomes ef f ective shall not exceed 12 (twelve) months.
PMHMETD II is expected to be implemented and completed in the first quarter of 2027.

                      PRELIMINARY OVERVIEW OF THE USE OF PROCEEDS

The Company will use all proceeds f rom PMHMETD II, af ter deducting all costs and expenses relat ed
to the issuance of the New Shares, f or the disbursement of f inancing to support the Company's business
growth.

Final and detailed inf ormation regarding the use of proceeds will be disclosed in the prospectus to be
issued in connection with PMHMETD II and made available in due course to eligible shareholders in
accordance with the prevailing laws and regulations.




                                                                                                      2

         ANALYSIS OF THE EFFECT OF PMHMETD II ON THE FINANCIAL CONDITION OF
                         THE COMPANY AND ITS SHAREHOLDERS

PMHMETD II is intended to strengthen the Company’s capital and increase its f inancing disbursement
capacity. Capital to support the Company’s business in 2027 is projected to increase f rom Rp51.07
trillion in 2026 to Rp64.41 trillion in 2027, while the capital adequacy ratio (CAR) is projected to increase
f rom 20.38% (twenty point three eight percent) to 23.31% (twenty three point three one percent).
Furthermore, the strengthening of the Company’s capital is expected to support the sustainable growth
of the Company’s business scale, including supporting its ef f orts to improve its bank classif ication based
on core capital in accordance with the prevailing laws and regulations.

The strengthened capital position is expected to support the Company’s sustainable business expansion
and f inancing growth. In the short term, the capital increase may af f ect profitability ratios, but these ratios
are expected to recover gradually as the f unds are disbursed into productive assets.

Shareholders who do not exercise their pre-emptive rights will be subject to ownership dilution of up to
12.85% (twelve point eight f ive percent). All such projections are indicative and depend on the f inal
structure and outcome of PMHMETD II.

                                        ADDITIONAL INFORMATION

Shareholders wishing to obtain additional inf ormation in connection with the proposed PMHMETD II may
contact the Company during business days and hours of the Company’s operational head of f ice at:

                                PT Bank Syariah Indonesia (Persero) Tbk.

                                              Head Office
                                          The Tower Building
                Jl. Gatot Subroto No. 27, Karet Semanggi Subdistrict, Setiabudi District
                                          South Jakarta 12930

                                 Email: corporate.secretary@bankbsi.co.id
                                        Website: www.bankbsi.co.id

                                           30 September 2026
                     Board of Directors of PT Bank Syariah Indonesia (Persero) Tbk




                                                                                                                3